GGrantIndex
← Leaderboards

Lisa A Croen

Kaiser Foundation Research Institute

Google Scholar ↗PubMed ↗ORCID ↗
$34,075,037
Attributed
$52,067,501
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.1M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$41,462,817 · 8
CDC$10,604,684 · 2

By mechanism

UH3$19,274,627 · 1
R01$12,340,145 · 6
UG3$9,848,045 · 1
U10$5,634,684 · 1
U01$4,970,000 · 1

Top collaborators

Most similar at Kaiser Foundation Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Child”

Research focus

ChildMothersPregnancyPrenatalNeurodevelopmentGeneticMediatingEnvironmental ExposureExposure ToCaliforniaCohortAutism Spectrum DisorderAffectDisorder RiskFundingNeurodevelopmental DisorderPatternFuturePregnant WomenGestational DiabetesBlood SpecimenEnvironmentFetalBiological Markers

Grant awards (44)

Maternal Autoantibody Reactivity, Gestational Inflammation, and Child Neurodevelopment (MARGIN)$685,131
R01 · FY2025 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,093,705
UG3 · FY2024 · OD
Maternal Autoantibody Reactivity, Gestational Inflammation, and Child Neurodevelopment (MARGIN)$686,871
R01 · FY2024 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,112,927
UG3 · FY2023 · OD
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,964,725
UH3 · FY2022 · OD
Maternal inflammation during pregnancy and neurodevelopmental disorders$608,950
R01 · FY2022 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,964,727
UH3 · FY2021 · OD
Maternal inflammation during pregnancy and neurodevelopmental disorders$622,136
R01 · FY2021 · HD · contact PI
Maternal inflammation during pregnancy and neurodevelopmental disorders$154,412
R01 · FY2021 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,964,727
UH3 · FY2020 · OD
Maternal inflammation during pregnancy and neurodevelopmental disorders$638,849
R01 · FY2020 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$310,572
UH3 · FY2020 · OD
Maternal Inflammation during Pregnancy and Neurodevelopmental Disorders$152,159
R01 · FY2020 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,709,938
UH3 · FY2019 · OD
Maternal inflammation during pregnancy and neurodevelopmental disorders$625,499
R01 · FY2019 · HD · contact PI
Prenatal SSRI Exposure, Maternal and Child Genotype, and Autism Spectrum Disorders$618,209
R01 · FY2019 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,359,938
UH3 · FY2018 · OD
Prenatal SSRI Exposure, Maternal and Child Genotype, and Autism Spectrum Disorders$644,772
R01 · FY2018 · HD · contact PI
Maternal inflammation during pregnancy and neurodevelopmental disorders$619,371
R01 · FY2018 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$2,203,040
UG3 · FY2017 · OD
Prenatal SSRI Exposure, Maternal and Child Genotype, and Autism Spectrum Disorders$666,304
R01 · FY2017 · HD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$1,438,373
UG3 · FY2016 · OD
Prenatal SSRI Exposure, Maternal and Child Genotype, and Autism Spectrum Disorders$684,768
R01 · FY2016 · HD · contact PI
California CADDRE-SEED Phase II$900,000
U01 · FY2015 · DD · contact PI
California CADDRE-SEED Phase II$1,100,000
U01 · FY2014 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$784,863
R01 · FY2014 · ES · contact PI
California CADDRE-SEED Phase II$1,050,000
U01 · FY2013 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$725,197
R01 · FY2013 · ES · contact PI
California CADDRE-SEED Phase II$1,020,000
U01 · FY2012 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$609,792
R01 · FY2012 · ES · contact PI
Prenatal and Neonatal Biologic Markers for Autism$129,464
R01 · FY2012 · ES · contact PI
California CADDRE-SEED Phase II$900,000
U01 · FY2011 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$610,723
R01 · FY2011 · ES · contact PI
National CADDRE Study: Child Development and Autism$1,539,577
U10 · FY2010 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$621,762
R01 · FY2010 · ES · contact PI
Prenatal Exposure to Polyfluoroalkyl Compounds in the EMA Study$130,465
R01 · FY2010 · ES · contact PI
National CADDRE Study: Child Development and Autism$1,386,673
U10 · FY2009 · DD · contact PI
Prenatal Exposure to Polyfluoroalkyl Compounds in the EMA Study$272,062
R01 · FY2009 · ES · contact PI
National CADDRE Study: Child Development and Autism$908,540
U10 · FY2008 · DD · contact PI
National CADDRE Study: Child Development and Autism$695,020
U10 · FY2007 · DD · contact PI
National CADDRE Study: Child Development and Autism$1,104,874
U10 · FY2006 · DD · contact PI
Prenatal and Neonatal Biologic Markers for Autism$295,856
R01 · FY2006 · MH · contact PI
Prenatal and Neonatal Biologic Markers for Autism$338,405
R01 · FY2005 · MH
Prenatal and Neonatal Biologic Markers for Autism$414,125
R01 · FY2004 · MH